Solar energy harvesting in magnetoelectric coupled manganese ferrite nanoparticles incorporated nanocomposite polymer films

Poly(vinylidenefluoride-co-trifluoroethylene) (P(VDF-TrFE)) based pyroelectric as well as magnetoelectric materials offer great promises for energy harvesting for flexible and wearable applications. Hence, this work focus on solar energy harvesting as well as magnetoelectric phenomenon in two phase nanocomposite film where the constituting phases are manganese ferrite (MnFe2O4) nanoparticles and P(VDF-TrFE) polymer. Composite films have been prepared using solution casting technique. X-ray diffraction result shows higher crystallinity of these films. The ferroelectric, magnetic and magnetoelectric properties in variation with applied field and volume percentage of ferrite nanoparticles have been investigated. The preparation condition was optimized in such a way that it results improved ferroelectric polarization of nanocomposite film after incorporation of small amount of ferrite nanoparticles. The maximum magnetoelectric-coupling coefficient of about 156 mV/Oe-Cm was obtained for optimum nanocomposite film when DC bias field was applied perpendicular to electric polarization direction. From a pyroelectric device perspective, solar energy harvesting is also reported. An open circuit voltage of 5V and short circuit current of order of ~1 nA is demonstrated without any pre amplification. Hence, the combination of magnetoelectric and pyroelectric properties of nanocomposite film presented here indicate as a perfect candidate for smart materials, spintronics devices and specified magnetoelectric-based applications

Disease Prevalence Due to Human Respiratory Syncytial Virus (HRSV) and Molecular Nature of G Gene in Different Geographical Region of India: 2005-2022

Human respiratory syncytial virus (hRSV) is the leading pediatric respiratory pathogen with high morbidity in the first year of life. The morbidity is particularly high in developing countries. it is the most common cause of infant hospitalization and causes a high burden of disease in the elderly. India is a country with vast geographical differences their unique climatic conditions. So, the prevalence of human RSV in different geographical regions is partially understood for a long time.  This review was performed by using a different search engine like Google schooler, PubMed, etc. Significant prevalence and specific RSV virus strain circulation were major keywords used for the search in the Indian pediatric population. Annual incidence rates of RSV–associated hospitalization per 1000 children were highest among infants aged 0–5 months, followed by ages 6–23 months, and lowest among children 24–59 months. hRSV was a substantial cause of hospitalization among children aged < 24 months especially those aged <6 months. Prevalence varies from 2.1% to 44% in different geographical regions. hRSV has a more broadly distributed peak timing. numerous studies of the correlation between climatic factors and hRSV incidence across latitudes found variable and inconsistent correlations between hRSV incidence & temperature, and relative humidity in different parts of the tropical region.However, genotypes ON1, NA1, GA5, and GA2 in the hRSV-A group and group hRSV-B BA, BA9, and BA12 were predominantly circulated in India

Effect of nano-size on magnetostriction of BiFeO3 and exceptional magnetoelectric coupling properties of BiFeO3_P(VDF-TrFE) polymer composite films for magnetic field sensor application

The existence of magnetostriction in bulk BiFeO3 is still a matter of investigation and it is also an issue to investigate the magnetostriction effect in nano BiFeO3. Present work demonstrates the existence of magnetostrictive strain in superparamagnetic BiFeO3 nanoparticles at room temperature and the magnetoelectric coupling properties in composite form with P(VDFTrFE). Despite few reports on the magnetostriction effect in bulk BiFeO3 evidenced by the indirect method, the direct method (strain gauge) was employed in this work to examine the magnetostriction of superparamagnetic BiFeO3. In addition, a high magnetoelectric coupling coefficient was observed by the lock-in technique for optimized BiFeO3_P(VDF-TrFE) nanocomposite film. These nanocomposite films also exhibit room-temperature multiferroic properties. These results provide aspects of material with immense potential for practical applications in spintronics and magneto-electronics applications. We report a magnetoelectric sensor using superparamagnetic BiFeO3_P(VDF-TrFE) nanocomposite film for detection of ac magnetic field

Biogenic synthesis of gold nanoparticles using Argemone mexicana L. and their cytotoxic and genotoxic effects on human colon cancer cell line (HCT-15)

Abstract Background Nanomedicine has evolved as precision medicine in novel therapeutic approach of cancer management. The present study investigated the efficacy of biogenic gold nanoparticles synthesized using Argemone mexicana L. aqueous extract (AM-AuNPs) against the human colon cancer cell line, HCT-15. Results Biosynthesis of AM-AuNPs was determined by ultraviolet-visible spectroscopy and further characterized by transmission electron microscopy, X-ray diffraction, and Fourier transition infrared spectroscopy analysis. The cytotoxic activity of AM-AuNPs was assessed by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay, whereas genotoxicity was evaluated by the DNA fragmentation assay. The expression of apoptosis regulatory genes such as p53 and caspase-3 was explored through semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and western blotting to evidence apoptotic cell death in HCT-15 cells. Biogenic AM-AuNPs inhibited cell proliferation in HCT-15 cell line with a half maximal inhibitory concentration (IC50) of 20.53 μg/mL at 24 h and 12.03 μg/mL at 48 h of exposure. The altered cell morphology and increased apoptosis due to AM-AuNPs were also evidenced through nuclear DNA fragmentation and upregulated expression of p53 and caspase-3 in HCT-15 cells. Conclusion The AM-AuNPs may exert antiproliferative and genotoxic effects on HCT-15 cells by cell growth suppression and induction of apoptosis mediated by activation of p53 and caspase-3 genes

Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety

Purpose: Glaucoma is the second leading cause of blindness worldwide, affecting more than 64 million people aged 40-80. The best way to manage primary open-angle glaucoma (POAG) is by lowering the intraocular pressure (IOP). Netarsudil is a Rho kinase inhibitor, the only class of antiglaucoma medications that reorganizes the extracellular matrix to improve the aqueous outflow through the trabecular pathway. Methods: An open-label, real-world, multicentric, observation-based 3-month study was performed for assessing the safety and ocular hypotensive efficacy of netarsudil ophthalmic solution (0.02% w/v) in patients with elevated IOP. Patients were given netarsudil ophthalmic solution (0.02% w/v) as a first-line therapy. Diurnal IOP measurements, best-corrected visual acuity, and adverse event assessments were recorded at each of the five visits (Day-1: screening day and first dosing day; subsequent observations were taken at 2 weeks, 4 weeks, 6 weeks, and 3 months). Results: Four hundred and sixty-nine patients from 39 centers throughout India completed the study. The mean IOP at baseline of the affected eyes was 24.84 ± 6.39 mmHg (mean ± standard deviation). After the first dose, the IOP was measured after 2, 4, and 6 weeks, with the final measurement taken at 3 months. The percentage reduction in IOP in glaucoma patients after 3 months of once-daily netarsudil 0.02% w/v solution use was 33.34%. The adverse effects experienced by patients were not severe in the majority of cases. Some adverse effects observed were redness, irritation, itching, and others, but only a small number of patients experienced severe reactions, as reported in a decreasing order: redness > irritation > watering > itching > stinging > blurring. Conclusion: We found that netarsudil 0.02% w/v solution monotherapy when used as the first-line treatment in primary open-angle glaucoma and ocular hypertension was both safe and effective